Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

By O. Glehen, F. Kwiatkowski, P. Sugarbaker, D. Elias, E. Levine, M. Simone, R. Barone, Y. Yonemura, F. Cavaliere, F. Quénet and 10 more. Journal of Clinical Oncology, 2004

1,181 citations recorded by the source corpus.

Subfields: Reproductive Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/30c6d478fdf8d85d003eedab32732b9b1adf68bc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Grothey
2. S. Kopetz
3. D. Sargent
4. M. Overman
5. S. Bruin
6. H. Boot
7. G. Slooten
8. H. Tinteren

Citations in the corpus

• Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. (2010, background): “It also underlines the strong impact of the completeness of CRS on the survival rate: the 5-year survival rate was 19% in the series by Glehen et al7; 53% were CCR-0.”
• Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. (2009, background): “For example, we did not separately evaluate patients undergoing surgical resection of metastatic disease at extrahepatic sites, although select patients seem to derive a benefit from resection of lung or peritoneal metastases.(21,22) How can these findings be applied to improve metastatic CRC outcom”
• 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer (2008, background): “Glehen et al.(10) analyzed, in 2004, all major phase studies.”